Rege Nephro
Developer of therapeutic drugs designed for patients suffering from renal failure. The company's drugs use core seed technology, pluripotent stem cells that produce erythropoietin (EPO), ureteral blas...
Valuation
$36.4M
Market implied
Share Price
N/A
Total Raised
$34.8M
Last Round
N/A